PEG化タンパク質市場レポート：製品別（消耗品、サービス）、タンパク質タイプ別（コロニー刺激因子、インターフェロン、エリスロポエチン、mAbs、遺伝子組換え第VII因子、その他）、用途別（がん治療、肝炎、慢性腎臓病、血友病、多発性硬化症、消化器疾患、その他）、エンドユーザー別（製薬・バイオテクノロジー企業、受託研究機関、学術・研究機関）、地域別 2024-2032

PEGylated Proteins Market Report by Product (Consumables, Services), Protein Type (Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VII, and Others), Application (Cancer Treatment, Hepatitis, Chronic Kidney Diseases, Hemophilia, Multiple Sclerosis, Gastrointestinal Disorders, and Others), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and Region 2024-2032

PEG化タンパク質の世界市場規模は2023年に13億米ドルに達した。今後、IMARC Groupは、市場が2032年までに28億米ドルに達し、2024年から2032年の間に8.87%の成長率（CAGR）を示すと予測している。慢性疾患の有病率... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
IMARC Services Private Limited. アイマークサービス	2024年1月30日	US$3,899 シングルユーザライセンスライセンス・価格情報注文方法はこちら	144	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

PEG化タンパク質の世界市場規模は2023年に13億米ドルに達した。今後、IMARC Groupは、市場が2032年までに28億米ドルに達し、2024年から2032年の間に8.87%の成長率（CAGR）を示すと予測している。慢性疾患の有病率の増加、癌治療における製品の利用拡大、PEG化タンパク質の製品承認数の増加は、市場を牽引する主な要因のいくつかである。

PEG化タンパク質は、ポリエチレングリコール（PEG）との共有結合によって修飾された生体分子である。PEG化は、生体分子のコンフォメーション、静電結合、疎水性などの物理的・化学的特性を変化させることにより、医薬品の薬物動態学的挙動を改善する技術である。PEG化タンパク質は、ワクチン、ホルモン補充療法、遺伝性疾患、貧血、血液凝固障害などの治療用途に広く使用されている。また、腎臓病、多発性硬化症、血友病、癌を含む様々な病気の治療薬にも使用されている。PEG化タンパク質は、半減期の延長、安定性、溶解性の向上、タンパク質分解保護、腎排泄、免疫原性、毒性の低減、薬物送達の有効性の向上に役立ちます。これに加えて、PEG化タンパク質は非毒性、水溶性、親水性、非抗原性、非免疫原性である。

PEG化タンパク質の市場動向：
世界中で腎臓病、自己免疫疾患、遺伝性疾患、肝炎、関節リウマチなどの慢性疾患の有病率が上昇していることが、市場成長を促進する主な要因の一つです。PEG化タンパク質は、炎症の治療、細胞への修正遺伝子の送達、血栓の予防、成長ホルモンの送達、慢性腎臓病の進行予防などに広く使用されている。これに伴い、化学療法薬をがん細胞に直接送達し、健康な細胞への副作用を軽減するために、がん治療において広く製品が利用されていることが、市場の成長に好影響を与えている。これとは別に、より小さく複雑な分子を製造できる新しいPEG化法の開発など、PEG化技術におけるさまざまな改良が市場成長に弾みをつけている。さらに、コロニー刺激因子（CSF）の安定性と半減期を改善し、治療薬としての効果を高めるためにPEG化が広く採用されていることも、成長を促進する要因となっている。さらに、非タンパク質ベースの薬剤よりもタンパク質ベースの薬剤の採用が増加しており、PEG化によってタンパク質の循環と半減期が増加し、効率が向上していることも市場成長を促進している。PEG化タンパク質の製品承認数の増加、バイオテクノロジーと分子生物学工学分野の発展、バイオ医薬品におけるPEG分子の統合と関連する利点、老人人口の増加、製薬業界における規制基準を高めるためのさまざまな政府イニシアチブの実施など、その他の要因も市場のさらなる成長を後押しすると予想されます。

主な市場セグメンテーション
IMARC Groupは、世界のPEG化タンパク質市場の各セグメントにおける主要動向の分析と、2024年から2032年までの世界、地域、国レベルでの予測を提供しています。当レポートでは、製品、タンパク質タイプ、用途、エンドユーザーに基づいて市場を分類しています。

製品の洞察

PEG化試薬
PEG化キット
フランス

本レポートでは、PEG化タンパク質市場を製品別に詳細に分類・分析している。これには消耗品（PEgylation試薬とPEgylationキット）とサービスが含まれる。レポートによると、消耗品が最大の市場シェアを占めている。

タンパク質タイプのインサイト

コロニー刺激因子
ーインターフェロン
エリスロポエチン
年
遺伝子組換え第VII因子
生殖補助因子

本レポートでは、PEG化タンパク質市場をタンパク質のタイプ別に詳細に分類・分析しています。これにはコロニー刺激因子、インターフェロン、エリスロポエチン、mAbs、組換え第VII因子、その他が含まれる。報告書によると、コロニー刺激因子が最大のセグメントを占めている。

アプリケーションの洞察

肝炎
慢性腎臓病
血友病
多発性硬化症
胃腸疾患

PEG化タンパク質市場の用途に基づく詳細な分類と分析も報告書に記載されています。これには、癌治療、肝炎、慢性腎臓病、血友病、多発性硬化症、胃腸障害、その他が含まれる。報告書によると、癌治療が最大のセグメントを占めている。

エンドユーザーの洞察

製薬・バイオテクノロジー企業
受託研究機関
学術・研究機関

本レポートでは、PEG化タンパク質市場をエンドユーザー別に詳細に分類・分析しています。これには製薬・バイオテクノロジー企業、受託研究機関、学術・研究機関が含まれる。同レポートによると、製薬・バイオテクノロジー企業が最大のセグメントを占めている。

地域別インサイト

北米
アメリカ
カナダ
欧州
ドイツ
フランス
イギリス
イタリア
スペイン
ロシア
その他
アジア太平洋
中国
日本
インド
韓国
オーストラリア
インドネシア
その他
ラテンアメリカ
ブラジル
メキシコ
その他
中東・アフリカ

また、北米（米国、カナダ）、欧州（ドイツ、フランス、英国、イタリア、スペイン、ロシア、その他）、アジア太平洋（中国、日本、インド、韓国、オーストラリア、インドネシア、その他）、中南米（ブラジル、メキシコ、その他）、中東・アフリカを含む主要地域市場の包括的な分析も行っている。報告書によると、北米はPEG化タンパク質の最大市場であった。北米のPEG化タンパク質市場を牽引する要因としては、老人人口の増加、慢性疾患の有病率の増加、広範な研究開発（R&D）などが挙げられる。

競争環境：
本レポートでは、世界のPEG化タンパク質市場における競争環境についても包括的に分析している。主要企業の詳細プロフィールも掲載しています。対象企業には、Abcam plc、Biomatrik Inc.、Creative PEGWorks、Iris Biotech GmbH、JenKem Technology USA Inc.、Laysan Bio Inc.、NOF America Corporation (NOF Corporation)、Profacgen、Thermo Fisher Scientific Inc.などが含まれる。

本レポートで回答した主な質問
1.PEG化タンパク質の世界市場規模は？
2.2024年から2032年にかけてのPEG化タンパク質の世界市場の予想成長率は？
3.PEG化タンパク質の世界市場を牽引する主な要因は？
4.COVID-19がPEG化タンパク質の世界市場に与えた影響は？
5.PEG化タンパク質の世界市場における製品別の内訳は？
6.タンパク質の種類に基づくPEG化タンパク質の世界市場の内訳は？
7.用途に基づくPEG化タンパク質の世界市場の内訳は？
8.エンドユーザーに基づくPEG化タンパク質の世界市場の内訳は？
9.PEG化タンパク質の世界市場における主要地域は？
10.PEG化タンパク質の世界市場における主要プレーヤー/企業は？

ページTOPに戻る

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global PEGylated Proteins Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Consumables
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 PEGylation Reagents
6.1.2.2 PEGylation Kits
6.1.3 Market Forecast
6.2 Services
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Protein Type
7.1 Colony Stimulating Factors
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Interferons
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Erythropoietin
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 mAbs
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Recombinant Factor VII
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 Market Breakup by Application
8.1 Cancer Treatment
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Hepatitis
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Chronic Kidney Diseases
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Hemophilia
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Multiple Sclerosis
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Gastrointestinal Disorders
8.6.1 Market Trends
8.6.2 Market Forecast
8.7 Others
8.7.1 Market Trends
8.7.2 Market Forecast
9 Market Breakup by End User
9.1 Pharmaceutical and Biotechnology Companies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Contract Research Organizations
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Academic and Research Institutes
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 Drivers, Restraints, and Opportunities
11.1 Overview
11.2 Drivers
11.3 Restraints
11.4 Opportunities
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abcam plc
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Biomatrik Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 Creative PEGWorks
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.4 Iris Biotech GmbH
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 JenKem Technology USA Inc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 Laysan Bio Inc.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 NOF America Corporation (NOF Corporation)
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.8 Profacgen
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.9 Thermo Fisher Scientific Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis

List of Figures
Figure 1: Global: PEGylated Proteins Market: Major Drivers and Challenges
Figure 2: Global: PEGylated Proteins Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: PEGylated Proteins Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: PEGylated Proteins Market: Breakup by Product (in %), 2023
Figure 5: Global: PEGylated Proteins Market: Breakup by Protein Type (in %), 2023
Figure 6: Global: PEGylated Proteins Market: Breakup by Application (in %), 2023
Figure 7: Global: PEGylated Proteins Market: Breakup by End User (in %), 2023
Figure 8: Global: PEGylated Proteins Market: Breakup by Region (in %), 2023
Figure 9: Global: PEGylated Proteins (Consumables) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: PEGylated Proteins (Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: PEGylated Proteins (Services) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: PEGylated Proteins (Services) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: PEGylated Proteins (Colony Stimulating Factors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: PEGylated Proteins (Colony Stimulating Factors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: PEGylated Proteins (Interferons) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: PEGylated Proteins (Interferons) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: PEGylated Proteins (Erythropoietin) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: PEGylated Proteins (Erythropoietin) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: PEGylated Proteins (mAbs) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: PEGylated Proteins (mAbs) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: PEGylated Proteins (Recombinant Factor VII) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: PEGylated Proteins (Recombinant Factor VII) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: PEGylated Proteins (Other Protein Types) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: PEGylated Proteins (Other Protein Types) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: PEGylated Proteins (Cancer Treatment) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: PEGylated Proteins (Cancer Treatment) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: PEGylated Proteins (Hepatitis) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: PEGylated Proteins (Hepatitis) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: PEGylated Proteins (Chronic Kidney Diseases) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: PEGylated Proteins (Chronic Kidney Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: PEGylated Proteins (Hemophilia) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: PEGylated Proteins (Hemophilia) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Global: PEGylated Proteins (Multiple Sclerosis) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Global: PEGylated Proteins (Multiple Sclerosis) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Global: PEGylated Proteins (Gastrointestinal Disorders) Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Global: PEGylated Proteins (Gastrointestinal Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: Global: PEGylated Proteins (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: Global: PEGylated Proteins (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: Global: PEGylated Proteins (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: Global: PEGylated Proteins (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Global: PEGylated Proteins (Contract Research Organizations) Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Global: PEGylated Proteins (Contract Research Organizations) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: Global: PEGylated Proteins (Academic and Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: Global: PEGylated Proteins (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: North America: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: North America: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: United States: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: United States: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: Canada: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: Canada: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: Asia-Pacific: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: Asia-Pacific: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: China: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: China: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: Japan: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: Japan: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: India: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: India: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: South Korea: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: South Korea: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Australia: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Australia: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: Indonesia: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: Indonesia: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: Others: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: Others: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: Europe: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: Europe: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Germany: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Germany: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: France: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: France: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: United Kingdom: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: United Kingdom: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Italy: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Italy: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Spain: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Spain: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Russia: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 80: Russia: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Others: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 82: Others: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 83: Latin America: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 84: Latin America: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 85: Brazil: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 86: Brazil: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 87: Mexico: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 88: Mexico: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 89: Others: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 90: Others: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 91: Middle East and Africa: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 92: Middle East and Africa: PEGylated Proteins Market: Breakup by Country (in %), 2023
Figure 93: Middle East and Africa: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 94: Global: PEGylated Proteins Industry: Drivers, Restraints, and Opportunities
Figure 95: Global: PEGylated Proteins Industry: Value Chain Analysis
Figure 96: Global: PEGylated Proteins Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: PEGylated Proteins Market: Key Industry Highlights, 2023 & 2032
Table 2: Global: PEGylated Proteins Market Forecast: Breakup by Product (in Million US$), 2024-2032
Table 3: Global: PEGylated Proteins Market Forecast: Breakup by Protein Type (in Million US$), 2024-2032
Table 4: Global: PEGylated Proteins Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 5: Global: PEGylated Proteins Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 6: Global: PEGylated Proteins Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: PEGylated Proteins Market: Competitive Structure
Table 8: Global: PEGylated Proteins Market: Key Players

ページTOPに戻る

Table of Contents

Summary

The global PEGylated proteins market size reached US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.8 Billion by 2032, exhibiting a growth rate (CAGR) of 8.87% during 2024-2032. The increasing prevalence of chronic diseases, the widespread product utilization in cancer treatment, and the escalating number of product approvals for PEGylated proteins represent some of the key factors driving the market.

PEGylated proteins are biomolecules that have been modified by covalent conjugation with polyethylene glycol (PEG). It involves the PEGylation technique that improves the pharmacokinetic behavior of the medicine by altering the biological molecule's physical and chemical characteristics, such as its conformation, electrostatic binding, and hydrophobicity. PEGylated proteins are widely used in therapeutic applications, such as vaccines, hormone replacement therapy, genetic disorders, anemia, and blood clotting disorder. It is also used in various drugs for diseases, including kidney disease, multiple sclerosis, hemophilia, and cancers. PEGylated proteins help in the extension of half-life, increasing stability, solubility, and proteolytic protection, reducing renal excretion, immunogenicity, and toxicity, and enhancing the efficacy of drug delivery. Besides this, PEGylated proteins are non-toxic, water-soluble, hydrophilic, non-antigenic, and non-immunogenic.

PEGylated Proteins Market Trends:
The rising prevalence of chronic diseases, such as kidney ailments, autoimmune diseases, genetic disorders, hepatitis, and rheumatoid arthritis across the globe is one of the key factors driving the market growth. PEGylated proteins are widely used to treat inflammation, deliver corrective genes to cells, prevent blood clots, deliver growth hormones, and prevent the progression of chronic kidney disease. In line with this, the widespread product utilization in cancer treatment to deliver chemotherapy drugs directly to cancer cells and reduce the side effects on healthy cells is favoring the market growth. Apart from this, various improvements in the PEGylation technology, such as the development of new PEGylation methods that can produce smaller and more complex molecules, are providing an impetus to the market growth. Additionally, the widespread adoption of PEGylation to improve the stability and half-life of colony-stimulating factors (CSFs), making them more effective as therapeutic agents, is acting as another growth-inducing factor. Furthermore, the rising adoption of protein-based drugs over non-protein-based drugs wherein PEGylation increases the circulation and half-life of the proteins, improving its efficiency, is propelling the market growth. Other factors, including the increasing number of product approvals for PEGylated proteins, development in the field of biotechnology and molecular biology engineering, the integration of PEG molecules in biopharmaceuticals and the associated advantages, rising geriatric population, and the implementation of various government initiatives to increase regulatory standards in the pharmaceutical industry, are anticipated drive the market further toward growth.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global PEGylated proteins market, along with forecasts at the global, regional, and country level from 2024-2032. Our report has categorized the market based on product, protein type, application, and end user.

Product Insights:

Consumables
PEGylation Reagents
PEGylation Kits
Services

A detailed breakup and analysis of the PEGylated proteins market based on the product has also been provided in the report. This includes consumables (PEgylation reagents and PEgylation kits) and services. According to the report, consumables accounted for the largest market share.

Protein Type Insights:

Colony Stimulating Factors
Interferons
Erythropoietin
mAbs
Recombinant Factor VII
Others

The report has provided a detailed breakup and analysis of the PEGylated proteins market based on the protein type. This includes colony stimulating factors, interferons, erythropoietin, mAbs, recombinant factor VII and others. According to the report, colony stimulating factors represented the largest segment.

Application Insights:

Cancer Treatment
Hepatitis
Chronic Kidney Diseases
Hemophilia
Multiple Sclerosis
Gastrointestinal Disorders
Others

A detailed breakup and analysis of the PEGylated proteins market based on the application has also been provided in the report. This includes cancer treatment, hepatitis, chronic kidney diseases, hemophilia, multiple sclerosis, gastrointestinal disorders, and others. According to the report, cancer treatment represented the largest segment.

End User Insights:

Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Academic and Research Institutes

The report has provided a detailed breakup and analysis of the PEGylated proteins market based on the end user. This includes pharmaceutical and biotechnology companies, contract research organizations, and academic and research institutes. According to the report, pharmaceutical and biotechnology companies represented the largest segment.

Regional Insights:

North America
United States
Canada
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for PEGylated proteins. Some of the factors driving the North America PEGylated proteins market included the rising geriatric population, increasing prevalence of chronic diseases, and extensive research and development (R&D).

Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global PEGylated proteins market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Abcam plc, Biomatrik Inc., Creative PEGWorks, Iris Biotech GmbH, JenKem Technology USA Inc., Laysan Bio Inc., NOF America Corporation (NOF Corporation), Profacgen, Thermo Fisher Scientific Inc., etc.

Key Questions Answered in This Report
1. How big is the global PEGylated proteins market?
2. What is the expected growth rate of the global PEGylated proteins market during 2024-2032?
3. What are the key factors driving the global PEGylated proteins market?
4. What has been the impact of COVID-19 on the global PEGylated proteins market?
5. What is the breakup of the global PEGylated proteins market based on the product?
6. What is the breakup of the global PEGylated proteins market based on the protein type?
7. What is the breakup of the global PEGylated proteins market based on the application?
8. What is the breakup of the global PEGylated proteins market based on the end user?
9. What are the key regions in the global PEGylated proteins market?
10. Who are the key players/companies in the global PEGylated proteins market?

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療）の最新刊レポート

IMARC Services Private Limited.社の医療分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問

IMARC Services Private Limited.社はどのような調査会社ですか?

インドに調査拠点を持つ調査会社。幅広い分野をカバーしていますがケミカルに特に焦点を当てています。もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医療）の最新刊レポート

IMARC Services Private Limited.社の医療分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

よくあるご質問

IMARC Services Private Limited.社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?